Innospec Inc (IOSP) FinancialsIOSPInnospec Inc

Innospec Inc (IOSP) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Performance Chemicals., accounting for 38.7% of total sales, equivalent to $190.30M. Other significant revenue streams include Fuel Specialties and Oilfield services. Understanding this composition is critical for investors evaluating how IOSP navigates market cycles within the Specialty Chemicals industry.

Evaluating the bottom line, Innospec Inc maintains a gross margin of 28.14%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.28%, while the net margin is 6.35%. These profitability ratios, combined with a Return on Equity (ROE) of 9.21%, provide a clear picture of how effectively IOSP converts its operational activities into shareholder value.

In the context of the broader market, IOSP competes directly with industry leaders such as NGVT and HUN. With a market capitalization of $2.35B, it holds a significant position in the sector. When comparing efficiency, IOSP's gross margin of 28.14% stands against NGVT's 44.25% and HUN's 14.73%. Such benchmarking helps identify whether Innospec Inc is trading at a premium or discount relative to its financial performance.

Innospec has shown solid financial performance with a gross margin of 28.14% in Q2 2026 and a net income of $30.8 million, indicating profitability despite some fluctuations in previous quarters.